Adaptable Proanthocyanidin Polymer Compositions for Congenital Diarrhea Disorder Treatment in Specialized Environments

Publication ID: 24-11857510_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Adaptable Proanthocyanidin Polymer Compositions for Congenital Diarrhea Disorder Treatment in Specialized Environments,” Published Technical Disclosure No. 24-11857510_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857510_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,510.

Summary of the Inventive Concept

This inventive concept adapts proanthocyanidin polymer compositions for treating congenital diarrhea disorder to specific, niche environments, including disaster relief, high-security facilities, extreme weather conditions, remote off-grid locations, and space exploration.

Background and Problem Solved

The original patent disclosed methods and compositions for treating congenital diarrhea disorder using proanthocyanidin polymer compositions. However, these compositions were not designed to address the unique challenges of specific, high-stress environments. This inventive concept solves the problem of adapting these compositions for use in disaster relief, high-security facilities, extreme weather conditions, remote off-grid locations, and space exploration, where traditional formulations may be ineffective or impractical.

Detailed Description of the Inventive Concept

The inventive concept comprises proanthocyanidin polymer compositions specifically designed for use in specialized environments. These compositions may be formulated in portable, waterproof containers for disaster relief, secure, tamper-evident containers for high-security facilities, heat-stable, freeze-dried formulations for extreme weather conditions, or microgravity-compatible, hermetically sealed containers for space exploration. Additionally, the inventive concept may include portable kits for remote, off-grid locations, comprising a proanthocyanidin polymer composition, a water purification system, and a solar-powered refrigeration unit. These adaptations enable effective treatment of congenital diarrhea disorder in a variety of challenging environments.

Novelty and Inventive Step

The inventive concept's novelty lies in its adaptation of proanthocyanidin polymer compositions for specific, niche environments, which is not addressed by the original patent. The inventive step is the recognition of the need for specialized formulations and packaging to address the unique challenges of these environments, and the development of compositions and systems that meet these needs.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include formulations adapted for use in other specialized environments, such as tropical or desert environments, or for use in conjunction with other medical treatments. Variations may include different proanthocyanidin polymer compositions, alternative packaging materials or designs, or integration with other medical devices or systems.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the pharmaceutical and medical device industries, particularly in the areas of disaster relief, high-security healthcare, and space exploration. The market for these specialized compositions and systems is likely to be niche, but high-value, and may include government agencies, non-governmental organizations, and private companies operating in these environments.

CPC Classifications

SectionClassGroup
A A61 A61K31/353
A A61 A61K9/0095
A A61 A61K9/28
A A61 A61K9/48
A A61 A61P1/04
A A61 A61P1/12

Original Patent Information

Patent NumberUS 11,857,510
TitleMethods and compositions for treating congenital diarrhea disorder
Assignee(s)NAPO PHARMACEUTICALS, INC.